key: cord-0850085-urrroc3k authors: Daruich, Alejandra; Martin, Daniel; Bremond-Gignac, Dominique title: Ocular manifestation as first sign of Coronavirus Disease 2019 (COVID-19): interest of telemedicine during the pandemic context date: 2020-04-17 journal: J Fr Ophtalmol DOI: 10.1016/j.jfo.2020.04.002 sha: 4b536c0b91720d86bfa1f7f106e000c19cc17119 doc_id: 850085 cord_uid: urrroc3k Abstract We report here the case of a 27-year-old man who consulted by telemedicine during the Coronavirus Disease 2019 (COVID-19) pandemic, due to foreign body sensation and left eye redness. Examination revealed unilateral eyelid edema and moderate conjunctival hyperemia. A few hours later the patient experienced intense headache and developed fever, cough and severe dyspnea. A nasopharyngeal swab proved positive for SARS-CoV-2. This case demonstrates that conjunctivitis can be the inaugural manifestation of the COVID-19 infection. It illustrates the interest of telemedicine in ophthalmology during the COVID-19 pandemic, since moderate conjunctival hyperemia can be the first sign of a severe respiratory distress. Telemedicine has been implemented worldwide in response of COVID-19 pandemic to bring medical care to patients while attempting to reduce the transmission of SARS-CoV-2 to patients, families, and healthcare staff (5-7). We present here the case of an otherwise healthy patient who consulted by telemedicine for ocular manifestations, and presented shortly thereafter a PCR-proven COVID-19. (SARS-CoV-2). Eleven days later, a second consultation by telemedicine showed that ocular signs had resolved. Dyspnea and cough were less severe but still present. We present here a case that illustrates the interest of telemedicine in an ophthalmological setting during the COVID-19 pandemic, where moderate conjunctival hyperemia was the presenting sign of the infection that rapidly progressed to respiratory distress. Ocular anomalies, including acute follicular conjunctivitis (8) , conjunctival hyperemia, chemosis, epiphora, and increased secretions have been reported in patients with COVID-19 (3). These manifestations have been observed to occur more patient in a series of 38 cases presenting with conjunctivitis as the initial manifestation of the disease (3) . Interestingly, in the present case ocular symptoms were the first manifestation of the disease that progressed within a few hours to a severe respiratory distress. Here, the patient presented unilateral manifestations, but bilateral follicular conjunctivitis has been also reported in a COVID-19 patient (8) . Additionally, only 5% of conjunctival swabs from patients with ocular manifestations have proven positive for SARS-CoV-2 (3), possibly indicating a low prevalence of the virus in conjunctival secretions and tears (1) . Alternatively, the virus could be present at the ocular surface, but with viral loads below the detection thresholds of existing PCR diagnosis techniques. Interestingly, our patient did not experience epiphora or secretions. Vision loss has not been reported among the ocular manifestations of COVID-19 (3, 8) which is in accordance with the case presented here. This case also illustrates the usefulness and relevance of teleophthalmology procedures during the COVID-19 epidemics, which, in addition to preventing the transmission of SARS-CoV-2, could help detect potentially COVID-19 patients. Ophthalmologists should be aware of these unusual ocular presentations of COVID-19 since they could precede the development of severe respiratory distress. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection Clinical Characteristics of Coronavirus Disease 2019 in China Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19 Can the Coronavirus Disease 2019 (COVID-19) Affect the Eyes? A Review of Coronaviruses and Ocular Implications in Humans and Animals Virtually Perfect? Telemedicine for Covid-19 Telemedicine in the Era of COVID-19 Telemedicine in the Time of Coronavirus Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease The authors thank Dr Hernan Gras for his medical contribution. The authors did not declare any conflict of interest.